The role of myokines and adipokines in hypertension and hypertension-related complications
Open accessAbstract
The cross-talk between skeletal muscle and adipose tissue has been identified to play a key role in the regulation of blood pressure and the development of hypertension. The role of different adipokines and myokines in hypertension and hypertension-related complications remains unclear. In the present study, 98 hypertensive patients and 24 normotensive controls were recruited, and additional subgroup analyses of hypertension-related complications were also performed. The levels of the circulating bone-derived factors leptin, apelin, fractalkine, brain-derived neurotrophic factor (BDNF), leukemia inhibitory factor (LIF), myostatin, fatty-acid-binding protein 3 (FABP3), irisin, follistatin-related protein 1 (FSTL1), oncostatin M, fibroblast growth factor 21 (FGF21) and musclin were measured by a protein liquid chip assay. The circulating levels of BDNF and musclin were decreased, whereas the leptin and irisin levels were increased, in hypertensive patients compared with those in the control individuals. Further logistic analysis indicated that the irisin level was positively correlated with SBP and an independent predictor for hypertension after adjustment. In nonobese subjects, the concentrations of DKK1, BDNF and FSTL1 were decreased, whereas the concentrations of leptin and irisin were increased. Irisin and DKK1 might be associated with hypertension. Additional subgroup analyses showed that irisin is significantly associated with hypertension-related stroke. In conclusion, we found that increased irisin levels are associated with hypertension and hypertension-related stroke. These findings indicate that irisin may be involved in the pathophysiology of hypertension.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
TNF-α and leptin seem to aggravate hypertension.
“These cytokines, especially TNF-α and leptin, seem to aggravate hypertension, which, together with visceral obesity, dyslipidemia, and hyperglycemia, configure the metabolic syndrome scenario [59,93].”
From Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions (2021) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271 · see citing works
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170 · see citing works
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810 · see citing works
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510 · see citing works
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909 · see citing works
Pescatello, L. S., Franklin, B. A., Fagard, R. H., Farquhar, W. B., Kelley, G. A., & Ray, C. A. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000115224.88514.3a · Cited by 1,918 · see citing works
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
Furie, K. L., Kasner, S. E., Adams, R. J., Albers, G. W., Bush, R. L., Fagan, S. C., Halperin, J. L., Johnston, S. C., Katzan, I. L., Kernan, W. N., et al. (2010) · Stroke · doi:10.1161/str.0b013e3181f7d043 · Cited by 1,492 · see citing works
Fihn, S. D., Blankenship, J. C., Alexander, K. P., Bittl, J. A., Byrne, J. G., Fletcher, B. J., Fonarow, G. C., Lange, R. A., Levine, G. N., Maddox, T. M., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000095 · Cited by 1,029 · see citing works
Inflammation, Immunity, and Hypertension
Harrison, D. G., Guzik, T. J., Lob, H. E., Madhur, M. S., Marvar, P. J., Thabet, S., Vinh, A., & Weyand, C. M. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.163576 · Cited by 877 · see citing works
Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.005 · Cited by 814 · see citing works
Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans
Lee, P., Linderman, J. D., Smith, S., Brychta, R. J., Wang, J., Idelson, C., Perron, R. M., Werner, C. D., Phan, G. Q., Kammula, U. S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.017 · Cited by 802 · see citing works
Self-citationObesity and cardiovascular disease: revisiting an old relationship
Koliaki, C. C., Liatis, S., & Kokkinos, A. D. (2018) · Metabolism · doi:10.1016/j.metabol.2018.10.011 · Cited by 733 · see citing works
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., Clement, D. L., Coca, A., SIMONE, G. D., Dominiczak, A. F., et al. (2018) · Blood Pressure · doi:10.1080/08037051.2018.1527177 · Cited by 710 · see citing works
Pedersen, B. K. (2013) · Comprehensive physiology · doi:10.1002/cphy.c120033 · Cited by 516 · see citing works
Fox, C. S., Golden, S. H., Anderson, C. A. M., Bray, G. A., Burke, L. E., de Boer, I. H., DEEDWANIA, P. C., Eckel, R. H., Ershow, A. G., FRADKIN, J. E., et al. (2015) · Diabetes Care · doi:10.2337/dci15-0012 · Cited by 491 · see citing works
Li, D., Li, Y., Yuan, H., Qu, L., & Wang, P. (2016) · Metabolism · doi:10.1016/j.metabol.2016.12.003 · Cited by 308 · see citing works
Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants.
Baradaran, A., Nasri, H., & Rafieian‐Kopaei, M. (2014) · Europe PMC (PubMed Central) · Cited by 296 · see citing works
Inflammation, Immunity, and Hypertension.
Agita, A., & Alsagaff, M. T. (2017) · Acta medica Indonesiana · Cited by 236 · see citing works
Irisin in patients with nonalcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., Anastasilakis, A. D., Geladari, E. V., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2013.09.013 · Cited by 215 · see citing works
Metabolic adaptation in obesity and type ii diabetes: myokines, adipokines and hepatokines
Oh, K.-J., Lee, D., Kim, W., Han, B., Lee, S., & Bae, K.-H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010008 · Cited by 210 · see citing works
Irisin protects mitochondria function during pulmonary ischemia/reperfusion injury
Chen, K., Xu, Z., Liu, Y., Wang, Z., Li, Y., Xu, X., Chen, C., Xia, T., Liao, Q., Yao, Y., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aao6298 · Cited by 208 · see citing works
Self-citationCross-talk between skeletal muscle and adipose tissue: A link with obesity?
Argilés, J. M. A., López‐Soriano, J., Almendro, V., Busquets, S., & López-Soriano, F. J. (2004) · Medicinal Research Reviews · doi:10.1002/med.20010 · Cited by 194 · see citing works
Crosstalk between adipokines and myokines in fat browning
Rodrı́guez, A., Becerril, S., Ezquerro, S., Méndez-Giménez, L., & Frühbeck, G. (2016) · Acta Physiologica · doi:10.1111/apha.12686 · Cited by 192 · see citing works
End Organ Damage In Hypertension
Schmieder, R. E. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0866 · Cited by 185 · see citing works
Role of Adipokines in Cardiovascular Disease
Lau, W. B., Ohashi, K., Wang, Y., Ogawa, H., Murohara, T., Ma, X., & Ouchi, N. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-0458 · Cited by 183 · see citing works
Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels
Lawes, C. M. M., Hoorn, S. V., Law, M. R., Elliott, P., MacMahon, S. W., & Rodgers, A. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000199801.72563.6f · Cited by 159 · see citing works
Serum levels of the myokine irisin in relation to metabolic and renal function
Ebert, T., Focke, D., Petroff, D., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1053 · Cited by 146 · see citing works
Fu, J.-J., Han, Y., Wang, J., Liu, Y., Zheng, S., Zhou, L., Jose, P., & Zeng, C. (2016) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.116.003433 · Cited by 139 · see citing works
Fihn, S. D., Blankenship, J. C., Alexander, K. P., Bittl, J. A., Byrne, J. G., Fletcher, B. J., Fonarow, G. C., Lange, R. A., Levine, G. N., Maddox, T. M., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.11.002 · Cited by 130 · see citing works
Wang, Z., Chen, K., Han, Y., Zhu, H., Zhou, X.-Y., Tan, T., Zeng, J., Zhang, J., Liu, Y., Li, Y., et al. (2018) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000608 · Cited by 116 · see citing works
Self-citationAsadi, Y., Gorjipour, F., Behrouzifar, S., & Vakili, A. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2569-9 · Cited by 111 · see citing works
Bailie, G. R., Uhlig, K., & Levey, A. S. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.4.491.61034 · Cited by 94 · see citing works
The role of adipokines in cardiovascular disease
Shibata, R., Ouchi, N., Ohashi, K., & Murohara, T. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.02.006 · Cited by 93 · see citing works
Central blood pressure and hypertension: role in cardiovascular risk assessment
Safar, M. E., & Jankowski, P. (2009) · Clinical Science · doi:10.1042/cs20080072 · Cited by 76 · see citing works
Morbid obesity and hypertension: The role of perirenal fat
Ricci, M. A., Scavizzi, M., Ministrini, S., VUONO, S. D., Pucci, G., & Lupattelli, G. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13370 · Cited by 72 · see citing works
Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke
Tu, W., Qiu, H., Cao, J., Liu, Q., Zeng, X., & Zhao, J.-Z. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0651-2 · Cited by 67 · see citing works
Dulian, K., Laskowski, R., Grzywacz, T., Kujach, S., Flis, D. J., Smaruj, M., & Ziemann, E. (2015) · Cryobiology · doi:10.1016/j.cryobiol.2015.10.143 · Cited by 63 · see citing works
An update on the role of adipokines in arterial stiffness and hypertension
Sabbatini, A. R., Fontana, V., Laurent, S., & Moreno, H. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000444 · Cited by 55 · see citing works
Zhang, L., Xie, Q., Tang, C., & Zhang, A. (2017) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2016.1273945 · Cited by 44 · see citing works
Increased Muscle Mass Protects Against Hypertension and Renal Injury in Obesity
Butcher, J. T., Mintz, J. D., Larion, S., Qiu, S., Ruan, L., Fulton, D. J., & Stepp, D. W. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009358 · Cited by 41 · see citing works
The Effects of Valsartan and Amlodipine on the Levels of Irisin, Adropin, and Perilipin
Çelik, H. T., Akkaya, N., Erdamar, H., Gök, S., Kazancı, F. H., Demirçelik, B., Çakmak, M., & Yiǧitoǧlu, M. R. (2015) · Clinical Laboratory · doi:10.7754/clin.lab.2015.150420 · Cited by 31 · see citing works
Lu, X., Ye, Z., Zheng, S., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007185 · Cited by 31 · see citing works
Muscle Attenuation Is Associated With Newly Developed Hypertension in Men of African Ancestry
Zhao, Q., Zmuda, J. M., Kuipers, A. L., Bunker, C. H., Patrick, A. L., Youk, A. O., & Miljkovic, I. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08415 · Cited by 24 · see citing works
The Global Burden of Disease Study 2015 and Blood Pressure
Kjeldsen, S. E., Narkiewicz, K., Burnier, M., et al. (2016) · Blood Pressure · doi:10.1080/08037051.2016.1267557 · Cited by 18 · see citing works
Elevated irisin and alanine aminotransferase levels in hypothyroidism: role of oxidative stress?
Halpern, B. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000166 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
de Oliveira dos Santos, A. R., de Oliveira Zanuso, B., Miola, V. F. B., Barbalho, S. M., Santos Bueno, P. C., Flato, U. A. P., Detregiachi, C. R. P., Buchaim, D. V., Buchaim, R. L., Tofano, R. J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052639 · Cited by 189 · see citing works
- Authors
- Chen, K., Zhou, M., Wang, X., Li, S., & Yang, D.
- Affiliations
- Chengdu Military General Hospital (CN)
- Corresponding author
- Yang, Dachun
- Venue
- Hypertension Research
- Published
- 2019-05-27
- Volume
- 42
- Issue
- 10
- Pages
- 1544-1551
- ISSN
- 0916-9636 (ISSN-L)
- 1348-4214
- PMC
- PMC8076012
- OpenAlex
- W2946965834
- Cited by
- 54
- References
- 46
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 14 · 2023: 6 · 2022: 11 · 2021: 8 · 2020: 5 · 2019: 1
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Hypertension Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81470396, 81770299, 81700371)
- China Postdoctoral Science Foundation
- Topics
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- myokines, adipokines, hypertension, irisin, leptin, brain-derived neurotrophic factor, musclin, DKK1, FSTL1, blood pressure, circulating biomarkers
- MeSH terms
- Adult, Aged, Blood Pressure, Female, Fibronectins, Humans, Hypertension, Male, Middle Aged, Muscle Proteins, Transcription Factors, Logistic Models, Case-Control Studies, Oxidative Stress, Brain-Derived Neurotrophic Factor, Adipokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
